Molecular Diagnosis of Lung Cancer
Lung cancer is still the leading cancer-related cause of death with a high incidence rate in the whole world. Treatment options – surgery, radiotherapy, and chemotherapy, depending on the stage of the disease. During the last decade, many molecular alterations were discovered that led to impressive...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Medical University - Pleven
2018-03-01
|
| Series: | Journal of Biomedical & Clinical Research |
| Subjects: | |
| Online Access: | https://jbcr.arphahub.com/article/34471/download/pdf/ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849409323173675008 |
|---|---|
| author | Savelina Popovska Tereza Dineva Polina Damyanova |
| author_facet | Savelina Popovska Tereza Dineva Polina Damyanova |
| author_sort | Savelina Popovska |
| collection | DOAJ |
| description | Lung cancer is still the leading cancer-related cause of death with a high incidence rate in the whole world. Treatment options – surgery, radiotherapy, and chemotherapy, depending on the stage of the disease. During the last decade, many molecular alterations were discovered that led to impressive changes in treatment. Personalized approaches, including target therapies with specific inhibitor drugs, became a part of the standard therapies. This article reviews current molecular biomarkers used in clinical practice to treat lung cancer patients. |
| format | Article |
| id | doaj-art-cfdc9c2f804244f499ea3c30b12083ce |
| institution | Kabale University |
| issn | 1313-9053 |
| language | English |
| publishDate | 2018-03-01 |
| publisher | Medical University - Pleven |
| record_format | Article |
| series | Journal of Biomedical & Clinical Research |
| spelling | doaj-art-cfdc9c2f804244f499ea3c30b12083ce2025-08-20T03:35:32ZengMedical University - PlevenJournal of Biomedical & Clinical Research1313-90532018-03-011029810310.1515/jbcr-2017-001634471Molecular Diagnosis of Lung CancerSavelina Popovska0Tereza DinevaPolina DamyanovaMedical University-PlevenLung cancer is still the leading cancer-related cause of death with a high incidence rate in the whole world. Treatment options – surgery, radiotherapy, and chemotherapy, depending on the stage of the disease. During the last decade, many molecular alterations were discovered that led to impressive changes in treatment. Personalized approaches, including target therapies with specific inhibitor drugs, became a part of the standard therapies. This article reviews current molecular biomarkers used in clinical practice to treat lung cancer patients.https://jbcr.arphahub.com/article/34471/download/pdf/molecular biomarkerslung cancertargeted therap |
| spellingShingle | Savelina Popovska Tereza Dineva Polina Damyanova Molecular Diagnosis of Lung Cancer Journal of Biomedical & Clinical Research molecular biomarkers lung cancer targeted therap |
| title | Molecular Diagnosis of Lung Cancer |
| title_full | Molecular Diagnosis of Lung Cancer |
| title_fullStr | Molecular Diagnosis of Lung Cancer |
| title_full_unstemmed | Molecular Diagnosis of Lung Cancer |
| title_short | Molecular Diagnosis of Lung Cancer |
| title_sort | molecular diagnosis of lung cancer |
| topic | molecular biomarkers lung cancer targeted therap |
| url | https://jbcr.arphahub.com/article/34471/download/pdf/ |
| work_keys_str_mv | AT savelinapopovska moleculardiagnosisoflungcancer AT terezadineva moleculardiagnosisoflungcancer AT polinadamyanova moleculardiagnosisoflungcancer |